Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04396223
Title Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment (TROPHAMET)
Acronym TROPHAMET
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Hospices Civils de Lyon
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.